The international pharmaceutical company Grünenthal opens an innovation hub in the Leiden Bio Science Park (LBSP). The LBSP is part of Medical Delta, the medical-technological consortium of the three universities, the Erasmus MC, and the Leiden University Medical Centre. By opening this innovation hub scientists and drug developers can work together even better.